| Member |
Title |
| Mr. Nicholas Gagnon |
Government and Stakeholder Relations
Pfizer Canada Inc. |
Mrs. Jean Gray
Chairperson of the
Working Group |
Professor Emeritus
Medical Education
Medicine and Pharmacology
Dalhousie University
(Human Drug Advisory Panel Member) |
| Mr. Edward Gudaitis |
General Manager
Gilead Sciences Canada |
| Ms. Lynn Macdonald |
Member of the Operations Committee
Best Medicine Coalition |
Ms. Martha Harczy, MD
MSc FRCPC |
Manager
Oncology - Bureau of Metabolism
Health Canada |
| Mr. Aidan Hollis |
Associate Professor Fellow
Institute for Advanced Policy Research |
| Mr. Don Holloway |
Vice-President
National Pensioners & Senior Citizens Federation of Canada |
| Mr. Olaf Koester |
Director
Drug Management Policy Unit
Manitoba Health |
| Mr. Eric Lun |
Executive Director
Drug Intelligence, Pharmaceutical Services
BC Ministry of Health |
| Dr. James McCormack |
Clinical Pharmacologist and Pharmacist
Professor & Acting Co-Chair -Clinical Pharmacy
University of British Columbia
(Human Drug Advisory Panel Member) |
| Ms. Claudia Neuber |
Senior Manager
Business Planning and Risk Management
AstraZeneca Canada Inc. |
| Ms. Sandy Pagotto |
Director
Common Drug Review (CDR) |
| Mr. Michael Paterson |
Pharmacoepidemiologist
Institute for Clinical Evaluative Sciences |
| Dr. Jian Wang |
Chief
Premarket Clinical Review
University of Calgary |
| Ms. Linda Wilhelm |
Canadian Arthritis Patient Alliance Chair of Access to Medications
Committee |